Clinical Trial Update: Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MEC chemotherapy (mitoxantrone, etoposide, cytarabine) with lenalidomide for relapsed or refractory acute myeloid leukemia has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Lenalidomide (lenalidomide)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: AML | Phase 2 | Status: COMPLETED | Results posted: 2021-02-03